DK1891962T3 - Glutathion-baseret afgivelsessystem - Google Patents
Glutathion-baseret afgivelsessystemInfo
- Publication number
- DK1891962T3 DK1891962T3 DK05292820.7T DK05292820T DK1891962T3 DK 1891962 T3 DK1891962 T3 DK 1891962T3 DK 05292820 T DK05292820 T DK 05292820T DK 1891962 T3 DK1891962 T3 DK 1891962T3
- Authority
- DK
- Denmark
- Prior art keywords
- glutathion
- delivery system
- based delivery
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyethers (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/303,934 US7446096B2 (en) | 2005-12-19 | 2005-12-19 | Glutathione based delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1891962T3 true DK1891962T3 (da) | 2014-10-13 |
Family
ID=36217526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05292820.7T DK1891962T3 (da) | 2005-12-19 | 2005-12-29 | Glutathion-baseret afgivelsessystem |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US7446096B2 (da) |
| EP (2) | EP1891962B1 (da) |
| JP (2) | JP4773200B2 (da) |
| CN (2) | CN101385859B (da) |
| CY (1) | CY1115542T1 (da) |
| DK (1) | DK1891962T3 (da) |
| ES (1) | ES2516665T3 (da) |
| PL (1) | PL1891962T3 (da) |
| PT (1) | PT1891962E (da) |
| SI (1) | SI1891962T1 (da) |
| TW (1) | TWI365754B (da) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR549901A0 (en) * | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| US20040057983A1 (en) | 2002-09-25 | 2004-03-25 | David Schmidt | Biomolecular wearable apparatus |
| JP4847437B2 (ja) * | 2004-03-03 | 2011-12-28 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | アルカロイド製剤 |
| BRPI0513673B8 (pt) * | 2004-08-03 | 2021-07-27 | Vital Health Sciences Pty Ltd | método para produzir um medicamento para aumentar a eficácia e o transporte dos compostos biologicamente ativos enteralmente administrados, e composição farmacêutica |
| US20090239827A1 (en) * | 2005-03-03 | 2009-09-24 | Esra Ogru | Compounds having lipid lowering properties |
| US9168216B2 (en) | 2005-06-17 | 2015-10-27 | Vital Health Sciences Pty. Ltd. | Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| US8067380B2 (en) * | 2005-12-19 | 2011-11-29 | Industrial Technology Research Institute | Glutathione-based delivery system |
| US7446096B2 (en) * | 2005-12-19 | 2008-11-04 | Industrial Technology Research Institute | Glutathione based delivery system |
| PL2308514T3 (pl) * | 2007-03-23 | 2013-11-29 | To Bbb Holding B V | Koniugaty do ukierunkowanego dostarczania leku poprzez barierę krew-mózg |
| FR2926725B1 (fr) * | 2008-01-25 | 2010-09-03 | Biochimie Appliquee Soc | Compositions cosmetiques et/ou dermatologiques cicatrisantes |
| US8602961B2 (en) | 2008-05-15 | 2013-12-10 | Lifewave Products Llc | Apparatus and method of stimulating elevation of glutathione levels in a subject |
| EP2368989A4 (en) | 2008-11-26 | 2012-09-26 | Chugai Pharmaceutical Co Ltd | OLIGORIBONUCLEOTID- BZW. PEPTID NUCLEIC ACID TO INHIBIT THE ACTIVITY OF HEPATITIS C VIRUS |
| CN102292069B (zh) * | 2008-11-26 | 2014-07-30 | 中外制药株式会社 | 囊泡制剂 |
| TR201908314T4 (tr) * | 2009-02-20 | 2019-06-21 | 2 Bbb Medicines B V | Glutatyon bazlı ilaç dağıtım sistemi. |
| EP2531047B1 (en) | 2010-02-05 | 2024-11-13 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| ES2829386T3 (es) | 2010-03-30 | 2021-05-31 | Phosphagenics Ltd | Parche de administración transdérmica |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| GB201302427D0 (en) | 2013-02-12 | 2013-03-27 | Midatech Ltd | Nanoparticle delivery compositions |
| US20150093399A1 (en) | 2013-08-28 | 2015-04-02 | Bioasis Technologies, Inc. | Cns-targeted conjugates having modified fc regions and methods of use thereof |
| JP6529012B2 (ja) | 2013-10-08 | 2019-06-12 | エイアイ・セラピューティクス・インコーポレーテッド | リンパ脈管筋腫症の処置のためのラパマイシン |
| US10765755B1 (en) * | 2013-11-20 | 2020-09-08 | University Of South Florida | Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies |
| NZ724756A (en) | 2014-04-04 | 2023-07-28 | Ai Therapeutics Inc | An inhalable rapamycin formulation for treating age-related conditions |
| WO2015154897A1 (en) * | 2014-04-08 | 2015-10-15 | Wolfgang Stremmel | Means and methods for treating disorders of copper metabolism |
| EP3131944B1 (en) * | 2014-04-17 | 2018-12-05 | The Corporation OF Mercer University | Vitamin e-based nanocarriers for drug delivery and methods of making and using the same |
| RU2732908C2 (ru) | 2014-10-07 | 2020-09-24 | ЭйАй ТЕРАПЬЮТИКС, ИНК. | Ингаляционная лекарственная форма рапамицина для лечения легочной гипертензии |
| US10758520B1 (en) | 2015-05-20 | 2020-09-01 | University Of South Florida | Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain barrier |
| MX383940B (es) | 2015-12-09 | 2025-03-14 | Phosphagenics Ltd | Formulación farmacéutica que contiene tocol fosfato. |
| IL267006B2 (en) | 2016-12-21 | 2024-11-01 | Phosphagenics Ltd | Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof |
| US10226442B2 (en) * | 2017-07-10 | 2019-03-12 | Syneurx International (Taiwan) Corp. | Lithium salts of N-substituted glycine compounds and uses thereof |
| US10842755B2 (en) | 2018-03-23 | 2020-11-24 | University Of South Carolina | Nanoparticles for brain targeted drug delivery |
| US20200048305A1 (en) * | 2018-08-10 | 2020-02-13 | South Dakota Board Of Regents | Glutathione-cholesterol derivatives as brain targeting agents |
| WO2020242217A1 (ko) * | 2019-05-28 | 2020-12-03 | 울산과학기술원 | 글루타치온-ｓ-전이효소 및 표적 세포 또는 표적 단백질 결합능을 갖는 단백질을 포함하는 리포좀 및 이의 용도 |
| CA3128035A1 (en) | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
| TW202228792A (zh) | 2020-10-09 | 2022-08-01 | 殷漢生技股份有限公司 | 吸入用奈米載體製劑 |
| CN118987236B (zh) * | 2024-08-12 | 2025-07-22 | 中山大学附属第一医院 | 基于谷胱甘肽响应微环境活性氧实现靶向药物递送的载体系统及其制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60142915A (ja) | 1983-12-28 | 1985-07-29 | Lion Corp | 口腔用組成物 |
| JPS632922A (ja) | 1986-06-20 | 1988-01-07 | Yamanouchi Pharmaceut Co Ltd | ドラツグキヤリア |
| JPH0714865B2 (ja) * | 1986-10-28 | 1995-02-22 | 武田薬品工業株式会社 | リポソ−ム製剤およびその製造法 |
| FR2627385B3 (fr) | 1988-02-23 | 1991-08-23 | Serobiologiques Lab Sa | Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques |
| US5695751A (en) | 1993-04-08 | 1997-12-09 | Cornell Research Foundation, Inc. | Enhancing delivery of large neutral amino acid drugs |
| JPH0834779A (ja) * | 1994-05-20 | 1996-02-06 | Senju Pharmaceut Co Ltd | トコフェロール誘導体 |
| US6653331B2 (en) | 1996-07-03 | 2003-11-25 | Pharmacia & Upjohn Company | Targeted drug delivery using sulfonamide derivatives |
| JP2001523221A (ja) * | 1996-09-01 | 2001-11-20 | ファーモス コーポレイション | 親油性物質の促進された生物学的利用能のための固形共沈物 |
| JP2001503396A (ja) * | 1996-10-11 | 2001-03-13 | アルザ コーポレイション | 治療用リポソーム組成物および方法 |
| US6228347B1 (en) | 1997-12-01 | 2001-05-08 | Thione International, Inc. | Antioxidant gel for gingival conditions |
| ATE297945T1 (de) | 1998-04-16 | 2005-07-15 | Teijin Ltd | Glutathionderivate und dazugehörige dosisformen |
| JP2004323486A (ja) * | 2003-04-30 | 2004-11-18 | National Institute Of Advanced Industrial & Technology | 網膜及び／又はブドウ膜疾患の予防乃至治療用点眼薬 |
| CN100515390C (zh) * | 2005-04-14 | 2009-07-22 | 蔡海德 | 垂体前叶肾上腺皮质提取物纳米脂质体组合药物及其制备方法和用途 |
| US7446096B2 (en) * | 2005-12-19 | 2008-11-04 | Industrial Technology Research Institute | Glutathione based delivery system |
| US8067380B2 (en) * | 2005-12-19 | 2011-11-29 | Industrial Technology Research Institute | Glutathione-based delivery system |
-
2005
- 2005-12-19 US US11/303,934 patent/US7446096B2/en not_active Expired - Lifetime
- 2005-12-27 JP JP2005374896A patent/JP4773200B2/ja not_active Expired - Lifetime
- 2005-12-29 SI SI200531880T patent/SI1891962T1/sl unknown
- 2005-12-29 DK DK05292820.7T patent/DK1891962T3/da active
- 2005-12-29 EP EP05292820.7A patent/EP1891962B1/en not_active Expired - Lifetime
- 2005-12-29 EP EP14180310.6A patent/EP2837384A1/en not_active Ceased
- 2005-12-29 PL PL05292820T patent/PL1891962T3/pl unknown
- 2005-12-29 ES ES05292820.7T patent/ES2516665T3/es not_active Expired - Lifetime
- 2005-12-29 PT PT52928207T patent/PT1891962E/pt unknown
- 2005-12-30 TW TW094147661A patent/TWI365754B/zh not_active IP Right Cessation
-
2006
- 2006-01-19 CN CN2008101693581A patent/CN101385859B/zh not_active Expired - Lifetime
- 2006-01-19 CN CN200610005869.0A patent/CN1985804B/zh not_active Expired - Lifetime
-
2007
- 2007-12-11 US US12/000,261 patent/US7704956B2/en not_active Expired - Fee Related
-
2008
- 2008-11-03 US US12/263,885 patent/US7700564B2/en not_active Expired - Lifetime
-
2010
- 2010-01-15 JP JP2010007125A patent/JP5394944B2/ja not_active Expired - Lifetime
- 2010-03-11 US US12/721,633 patent/US8569239B2/en active Active
-
2014
- 2014-09-10 CY CY20141100728T patent/CY1115542T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007169252A (ja) | 2007-07-05 |
| US20090060991A1 (en) | 2009-03-05 |
| JP2010150264A (ja) | 2010-07-08 |
| CN101385859B (zh) | 2011-12-07 |
| US20100166849A1 (en) | 2010-07-01 |
| CN101385859A (zh) | 2009-03-18 |
| CY1115542T1 (el) | 2017-01-04 |
| US7700564B2 (en) | 2010-04-20 |
| PT1891962E (pt) | 2014-11-11 |
| SI1891962T1 (sl) | 2014-12-31 |
| JP5394944B2 (ja) | 2014-01-22 |
| TWI365754B (en) | 2012-06-11 |
| CN1985804A (zh) | 2007-06-27 |
| ES2516665T3 (es) | 2014-10-31 |
| EP1891962B1 (en) | 2014-08-13 |
| PL1891962T3 (pl) | 2015-01-30 |
| US7446096B2 (en) | 2008-11-04 |
| CN1985804B (zh) | 2014-05-14 |
| JP4773200B2 (ja) | 2011-09-14 |
| US7704956B2 (en) | 2010-04-27 |
| EP1891962A1 (en) | 2008-02-27 |
| EP2837384A1 (en) | 2015-02-18 |
| US20080095836A1 (en) | 2008-04-24 |
| US8569239B2 (en) | 2013-10-29 |
| US20070141133A1 (en) | 2007-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1891962T3 (da) | Glutathion-baseret afgivelsessystem | |
| DK1889198T3 (da) | Farma-informatiksystem | |
| DK1928521T3 (da) | Trombektomikateterindsættelsessystem | |
| FI20060131A0 (fi) | Yhteysjärjestelmä | |
| FI20050128L (fi) | Hissijärjestelmä | |
| DE602006003400D1 (de) | Embolievorrichtungs-Abgabesystem | |
| FI20050127A0 (fi) | Hissijärjestelmä | |
| DE602006015148D1 (de) | Embolievorrichtung Abgabesystem | |
| FI20050361L (fi) | Hissijärjestelmä | |
| DE502006007103D1 (de) | Anschluss-system | |
| DK1957073T3 (da) | Lægemiddel | |
| EP1964232A4 (en) | HVDC SYSTEM | |
| DE602007009224D1 (de) | R-cellular-systemen | |
| NL1030597A1 (nl) | Geurafgiftesysteem. | |
| NL1030571A1 (nl) | Geurafgiftesysteem. | |
| DE602006018435D1 (de) | Surround-System | |
| EP1951798A4 (en) | BROMOBENZYLE FIRE RETARDANT SYSTEMS | |
| ATE454037T1 (de) | Haltesystem | |
| DK1769359T3 (da) | Publikationsdata-verifikationssystem | |
| LU91233B1 (de) | Laderaumsystem | |
| FI6455U1 (fi) | Virtuaali-ikkunajärjestelmä | |
| SK4298U (sk) | Doručenka | |
| SK4297U (sk) | Doručenka | |
| ITMO20050280A1 (it) | Apparato pulitore | |
| DK2392258T3 (da) | Farma-informatiksystem |